{"entity":{"type":"insider","cik":"0001612312","url":"/insider/0001612312","json_url":"/insider/0001612312.json","name":"Bilenker Joshua H.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":171,"n_filings":18,"first":"2017-08-16","last":"2023-02-17","span_basis":"filed_date"},"name_variants":[{"name":"Bilenker Joshua H.","source":"filing","n_filings":18,"first_seen":"2017-08-16","last_seen":"2023-02-17"}],"transactions":[{"id":8591543,"accession":"0001562180-23-001518","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-23-001518","line_url":"/filing/0001562180-23-001518#line-1","is_derivative":false,"issuer_cik":"0001612312","issuer_name":"Sana Biotechnology, Inc.","issuer_ticker":"SANA","issuer_name_source":null,"issuer_url":"/issuer/0001612312","owner_cik":"0001612312","owner_name":"Bilenker Joshua H.","owner_display_name":"Bilenker Joshua H.","owner_url":"/insider/0001612312","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":25.0,"price_display":"25.00","price_state":"stated","total_value":500000.0,"total_display":"500,000.00","total_whole":"500,000","shares_owned_after":20000.0,"shares_owned_after_display":"20,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-03","filed_date":"2023-02-17","scope":"insider"},{"id":6428278,"accession":"0001567619-18-007783","txn_seq":16,"anchor":"line-16","filing_url":"/filing/0001567619-18-007783","line_url":"/filing/0001567619-18-007783","is_derivative":false,"issuer_cik":"0001581720","issuer_name":"Loxo Oncology, Inc.","issuer_ticker":"LOXO","issuer_name_source":null,"issuer_url":"/issuer/0001581720","owner_cik":"0001612312","owner_name":"Bilenker Joshua H.","owner_display_name":"Bilenker Joshua H.","owner_url":"/insider/0001612312","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":137.423677,"price_display":"137.42","price_state":"stated","total_value":1374236.77,"total_display":"1,374,236.77","total_whole":"1,374,237","shares_owned_after":169214.0,"shares_owned_after_display":"169,214","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-11","filed_date":"2018-12-12","scope":"insider","n_lines":7},{"id":6428257,"accession":"0001567619-18-007783","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001567619-18-007783","line_url":"/filing/0001567619-18-007783","is_derivative":false,"issuer_cik":"0001581720","issuer_name":"Loxo Oncology, Inc.","issuer_ticker":"LOXO","issuer_name_source":null,"issuer_url":"/issuer/0001581720","owner_cik":"0001612312","owner_name":"Bilenker Joshua H.","owner_display_name":"Bilenker Joshua H.","owner_url":"/insider/0001612312","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":133.519838,"price_display":"133.52","price_state":"stated","total_value":1335198.38,"total_display":"1,335,198.38","total_whole":"1,335,198","shares_owned_after":164907.0,"shares_owned_after_display":"164,907","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-10","filed_date":"2018-12-12","scope":"insider","n_lines":7},{"id":6103233,"accession":"0001567619-18-007046","txn_seq":21,"anchor":"line-21","filing_url":"/filing/0001567619-18-007046","line_url":"/filing/0001567619-18-007046","is_derivative":false,"issuer_cik":"0001581720","issuer_name":"Loxo Oncology, Inc.","issuer_ticker":"LOXO","issuer_name_source":null,"issuer_url":"/issuer/0001581720","owner_cik":"0001612312","owner_name":"Bilenker Joshua H.","owner_display_name":"Bilenker Joshua H.","owner_url":"/insider/0001612312","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":141.341755,"price_display":"141.34","price_state":"stated","total_value":1413417.55,"total_display":"1,413,417.55","total_whole":"1,413,418","shares_owned_after":169440.0,"shares_owned_after_display":"169,440","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-27","filed_date":"2018-11-28","scope":"insider","n_lines":11},{"id":6103202,"accession":"0001567619-18-007046","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001567619-18-007046","line_url":"/filing/0001567619-18-007046","is_derivative":false,"issuer_cik":"0001581720","issuer_name":"Loxo Oncology, Inc.","issuer_ticker":"LOXO","issuer_name_source":null,"issuer_url":"/issuer/0001581720","owner_cik":"0001612312","owner_name":"Bilenker Joshua H.","owner_display_name":"Bilenker Joshua H.","owner_url":"/insider/0001612312","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":153.182937,"price_display":"153.18","price_state":"stated","total_value":1531829.37,"total_display":"1,531,829.37","total_whole":"1,531,829","shares_owned_after":169952.0,"shares_owned_after_display":"169,952","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-26","filed_date":"2018-11-28","scope":"insider","n_lines":6},{"id":6598038,"accession":"0001567619-18-003758","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0001567619-18-003758","line_url":"/filing/0001567619-18-003758","is_derivative":false,"issuer_cik":"0001581720","issuer_name":"Loxo Oncology, Inc.","issuer_ticker":"LOXO","issuer_name_source":null,"issuer_url":"/issuer/0001581720","owner_cik":"0001612312","owner_name":"Bilenker Joshua H.","owner_display_name":"Bilenker Joshua H.","owner_url":"/insider/0001612312","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":162.62460515,"price_display":"162.62","price_state":"stated","total_value":1626246.0515,"total_display":"1,626,246.05","total_whole":"1,626,246","shares_owned_after":139002.0,"shares_owned_after_display":"139,002","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-10-04","filed_date":"2018-10-05","scope":"insider","n_lines":6},{"id":6598022,"accession":"0001567619-18-003758","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001567619-18-003758","line_url":"/filing/0001567619-18-003758","is_derivative":false,"issuer_cik":"0001581720","issuer_name":"Loxo Oncology, Inc.","issuer_ticker":"LOXO","issuer_name_source":null,"issuer_url":"/issuer/0001581720","owner_cik":"0001612312","owner_name":"Bilenker Joshua H.","owner_display_name":"Bilenker Joshua H.","owner_url":"/insider/0001612312","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7095.0,"shares_display":"7,095","price_per_share":168.18234472163496,"price_display":"168.18","price_state":"stated","total_value":1193253.7358,"total_display":"1,193,253.74","total_whole":"1,193,254","shares_owned_after":135602.0,"shares_owned_after_display":"135,602","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-10-03","filed_date":"2018-10-05","scope":"insider","n_lines":5},{"id":6402617,"accession":"0001567619-18-002677","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0001567619-18-002677","line_url":"/filing/0001567619-18-002677","is_derivative":false,"issuer_cik":"0001581720","issuer_name":"Loxo Oncology, Inc.","issuer_ticker":"LOXO","issuer_name_source":null,"issuer_url":"/issuer/0001581720","owner_cik":"0001612312","owner_name":"Bilenker Joshua H.","owner_display_name":"Bilenker Joshua H.","owner_url":"/insider/0001612312","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":165.98054038,"price_display":"165.98","price_state":"stated","total_value":1659805.4038,"total_display":"1,659,805.40","total_whole":"1,659,805","shares_owned_after":139771.0,"shares_owned_after_display":"139,771","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-09-13","filed_date":"2018-09-14","scope":"insider","n_lines":3},{"id":6402606,"accession":"0001567619-18-002677","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001567619-18-002677","line_url":"/filing/0001567619-18-002677#line-8","is_derivative":false,"issuer_cik":"0001581720","issuer_name":"Loxo Oncology, Inc.","issuer_ticker":"LOXO","issuer_name_source":null,"issuer_url":"/issuer/0001581720","owner_cik":"0001612312","owner_name":"Bilenker Joshua H.","owner_display_name":"Bilenker Joshua H.","owner_url":"/insider/0001612312","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3700.0,"shares_display":"3,700","price_per_share":165.1821,"price_display":"165.18","price_state":"stated","total_value":611173.77,"total_display":"611,173.77","total_whole":"611,174","shares_owned_after":141007.0,"shares_owned_after_display":"141,007","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-09-12","filed_date":"2018-09-14","scope":"insider"},{"id":6402602,"accession":"0001567619-18-002677","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001567619-18-002677","line_url":"/filing/0001567619-18-002677#line-7","is_derivative":false,"issuer_cik":"0001581720","issuer_name":"Loxo Oncology, Inc.","issuer_ticker":"LOXO","issuer_name_source":null,"issuer_url":"/issuer/0001581720","owner_cik":"0001612312","owner_name":"Bilenker Joshua H.","owner_display_name":"Bilenker Joshua H.","owner_url":"/insider/0001612312","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2400.0,"shares_display":"2,400","price_per_share":166.4875,"price_display":"166.49","price_state":"stated","total_value":399570.0,"total_display":"399,570.00","total_whole":"399,570","shares_owned_after":138607.0,"shares_owned_after_display":"138,607","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-09-12","filed_date":"2018-09-14","scope":"insider"},{"id":6402600,"accession":"0001567619-18-002677","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001567619-18-002677","line_url":"/filing/0001567619-18-002677#line-6","is_derivative":false,"issuer_cik":"0001581720","issuer_name":"Loxo Oncology, Inc.","issuer_ticker":"LOXO","issuer_name_source":null,"issuer_url":"/issuer/0001581720","owner_cik":"0001612312","owner_name":"Bilenker Joshua H.","owner_display_name":"Bilenker Joshua H.","owner_url":"/insider/0001612312","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1800.0,"shares_display":"1,800","price_per_share":167.3814,"price_display":"167.38","price_state":"stated","total_value":301286.52,"total_display":"301,286.52","total_whole":"301,287","shares_owned_after":136807.0,"shares_owned_after_display":"136,807","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-09-12","filed_date":"2018-09-14","scope":"insider"},{"id":6402598,"accession":"0001567619-18-002677","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001567619-18-002677","line_url":"/filing/0001567619-18-002677#line-5","is_derivative":false,"issuer_cik":"0001581720","issuer_name":"Loxo Oncology, Inc.","issuer_ticker":"LOXO","issuer_name_source":null,"issuer_url":"/issuer/0001581720","owner_cik":"0001612312","owner_name":"Bilenker Joshua H.","owner_display_name":"Bilenker Joshua H.","owner_url":"/insider/0001612312","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":800.0,"shares_display":"800","price_per_share":168.5125,"price_display":"168.51","price_state":"stated","total_value":134810.0,"total_display":"134,810.00","total_whole":"134,810","shares_owned_after":136007.0,"shares_owned_after_display":"136,007","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-09-12","filed_date":"2018-09-14","scope":"insider"}],"collapsed":true,"next_cursor":"2018-09-12|6402598","ledger_fault":false,"count":{"value":171,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":170,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":171},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001770121","name":"Sana Biotechnology, Inc.","url":"/issuer/0001770121","role":"Director","n_filings":1,"first_seen":"2023-02-17","last_seen":"2023-02-17"},{"type":"issuer","type_label":"ISSUER","cik":"0001581720","name":"Loxo Oncology, Inc.","url":"/issuer/0001581720","role":"Director, Officer (President & CEO)","n_filings":17,"first_seen":"2017-08-16","last_seen":"2018-12-12"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001612312","retrieved_at":"2026-08-26T21:42:31+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}